Consideration of gene therapy for paediatric neurotransmitter diseases

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2009-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10545-009-1054-7PMID 19259783PMCID PMC4848069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical development of gene therapy for Parkinson's disease.

  2008cited by this paper
• Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

  2008cited by this paper
• Towards gene therapy for Parkinson's disease.

  2008cited by this paper
• Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity.

  2008influential reference
• Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

  2008cited by this paper
• Design of clinical trials of gene therapy in Parkinson disease.

  2008cited by this paper
• Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

  2008cited by this paper
• Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

  2008cited by this paper
• Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system.

  2008cited by this paper
• Potential of AAV vectors in the treatment of metabolic disease

  2008cited by this paper
• Deep brain stimulation for Parkinson’s disease

  2008cited by this paper
• Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

  2008cited by this paper
• The Pediatric Neurotransmitter Disorders

  2007cited by this paper
• Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

  2007cited by this paper
• Comparative Analysis of Adeno-Associated Viral Vector Serotypes 1, 2, 5, 7, And 8 in Mouse Brain

  2007influential reference
• Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

  2007cited by this paper
• Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment

  2007cited by this paper
• Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.

  2006cited by this paper
• Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.

  2005influential reference
• Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.

  2005cited by this paper
• Cell transplantation in Parkinson's disease: how can we make it work?

  2005influential reference
• Administration of a Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children with Late Infantile Neuronal Ceroid Lipofuscinosis

  2004cited by this paper
• GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats

  2004cited by this paper
• Serotonin and brain development.

  2004cited by this paper
• Dwarfism and Low Insulin-like Growth Factor-1 Due to Dopamine Depletion in Pts–/– Mice Rescued by Feeding Neurotransmitter Precursors and H4-biopterin*

  2003cited by this paper
• A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

  2003cited by this paper
• Biogenic Amines and Polyamines: Similar Biochemistry for Different Physiological Missions and Biomedical Applications

  2003cited by this paper
• The hph‐1 mouse: A model for dominantly inherited GTP‐cyclohydrolase deficiency

  2003influential reference
• Potential of gene therapy for pediatric neurotransmitter diseases: Lessons from Parkinson's disease

  2003cited by this paper
• Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of l-dopa using rAAV-mediated gene transfer

  2002cited by this paper
• Adenovirus and Adeno-Associated Virus Vectors

  2002cited by this paper
• Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic l-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model of Parkinson's Disease.

  2002cited by this paper
• Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain

  2002cited by this paper
• Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model

  2002cited by this paper
• Dopamine-Dependent Desensitization of Dopaminergic Signaling in the Developing Mouse Striatum

  2002cited by this paper
• Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

  2001cited by this paper
• Reconstitution of a metabolic pathway with triple‐cistronic IRES‐containing retroviral vectors for correction of tetrahydrobiopterin deficiency

  2000cited by this paper
• Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease.

  1999cited by this paper
• Vesicular Monoamine Transporter-2 and Aromaticl-Amino Acid Decarboxylase Enhance Dopamine Delivery afterl-3,4-Dihydroxyphenylalanine Administration in Parkinsonian Rats

  1999influential reference
• Retrovirus‐Mediated Double Transduction of the GTPCH and PTPS Genes Allows 6‐Pyruvoyltetrahydropterin Synthase‐Deficient Human Fibroblasts to Synthesize and Release Tetrahydrobiopterin

  1998influential reference
• Role of Aromatic l‐Amino Acid Decarboxylase for Dopamine Replacement by Genetically Modified Fibroblasts in a Rat Model of Parkinson's Disease

  1997cited by this paper
• Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis ofl-DOPA by Primary Fibroblasts

  1996influential reference
• Retrovirus-Mediated Gene Transfer of 6-Pyruvoyl-Tetrahydropterin Synthase Corrects Tetrahydrobiopterin Deficiency in Fibroblasts from Hyperphenylalaninemic Patients

  1996cited by this paper
• Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.

  1995influential reference
• Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development

  1995cited by this paper
• Molecular characterization of HPH-1: a mouse mutant deficient in GTP cyclohydrolase I activity.

  1994cited by this paper
• Gene therapy

  1993cited by this paper
• Structure and function of the brain serotonin system.

  1992cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture.

  1986cited by this paper

• Gene therapy for neurotransmitter‐related disorders

  2024cites this paper
• Gene therapy for ultrarare diseases: a geneticist’s perspective

  2024cites this paper
• Understanding ayahuasca effects in major depressive disorder treatment through invitro metabolomics and bioinformatics

  2023cites this paper
• Exploring the genetic landscape of neurotransmitter alterations in hypoxic-ischemic encephalopathy: A personalized medicine perspective

  2023cites this paper
• The Role of B Group Vitamins and Choline in Cognition and Brain Aging

  2017cites this paper